Literature DB >> 36237563

Invasive Listeriosis: Molecular Determinants of Virulence and Antimicrobial Resistance.

Naveen Kumar1, Angel T Miraclin2, Karthik Gunasekaran3, Balaji Veeraraghavan1.   

Abstract

Entities:  

Year:  2022        PMID: 36237563      PMCID: PMC9552339          DOI: 10.4103/jgid.jgid_94_22

Source DB:  PubMed          Journal:  J Glob Infect Dis        ISSN: 0974-777X


× No keyword cloud information.
Sir, Human listeriosis causes severe disease and, when invasive, leads to high fatality rates. Clinical spectrum is varied with septicemia being more common, followed by meningoencephalitis in immunocompromised individuals and elderly.[123] Listeria monocytogenes (Lm) has a higher misdiagnosis rate with fast progression and poor prognosis.[45] Conventional culture method using blood or cerebrospinal fluid is time-consuming and has very low positive detection rate.[6] Despite adequate antibiotic treatment, the overall mortality is still high (25%–30%) and neurological sequelae are frequent. In this short report, we describe three clinical cases of Lm identified using conventional method; subsequently, the strains were characterized using next-generation sequencing. The clinical and microbiological characteristics of the isolates of the three patients are summarized in [Table 1]. All the three patients had risk factors such as type 2 diabetes mellitus, systemic hypertension, chronic kidney disease stage 5, lung fibrosis, and malignancy (germ cell tumor), which leads to impaired cell-mediated immunity, further predisposing to severe infection. ResFinder revealed only fosX gene in all three genomes. Accordingly, the study isolates were resistant to cephalosporins and susceptible to ampicillin, penicillin, and SXT (Trimethoprim/Sulphamethoxazole). Very few compounds have a bactericidal effect on Lm cells. Ampicillin or penicillin G was reported to be the best treatment options for listeriosis based on their bacteriostatic effect. The combination of AMP/PEN in combination with gentamicin will enhance the bactericidal effect of the therapy.[7]
Table 1

Clinical and microbiological characteristics of listeria isolates

IDClinical syndromeRisk factorsPatient outcomePenicillin (±g/ml)TMP/SMX (±g/ml)oatAPBP3Acquired genesEfflux genes
ALower respiratory tract infectionPosttuberculosis sequelaeLost to follow-up0.750.064S96A, D440E, After 433 DK insertion, After 442 DSKE insertion, A443T, S445A, S449N, E450G, K452N, E453Q, K456V, S463T, I470M, D539E, A576S, and A607SG66S, N98D, D171E, A223D, P236A, T580A, K584A, E608Q, and I650V.fosX, mblfosX, mblmepA, msrA, norB
BMeningo-encephalitisType 2 diabetes mellitusSystemic hypertensionChronic kidney disease stage 5Recovered0.750.064--fosX, mblmepA, msrA, norB, mdrT (lmo2588)
CSepticaemiaMalignancyExpired0.250.064fosX, mblmepA, msrA, norB, mdrT (lmo2588)

PBP3: Penicillin-binding protein 3, TMP/SMX: Trimethoprim/Sulphamethoxazole

Clinical and microbiological characteristics of listeria isolates PBP3: Penicillin-binding protein 3, TMP/SMX: Trimethoprim/Sulphamethoxazole Intrinsic resistance to cephalosporins was reported to be mediated by oatA mutations and PBP3 mutations. In the study isolates, the site of insertions and non-sense mutation in oatA were in S96A, D440E, after 433 DK insertion, after 442 DSKE insertion, A443T, S445A, S449N, E450G, K452N, E453Q, K456V, S463T, I470M, D539E, A576S, and A607S. Regions of mutations in PBP3 were G66S, N98D, D171E, A223D, P236A, T580A, K584A, E608Q, and I650V [Figure 1]. OatA mutants were known to induce early secretion of proinflammatory cytokines and chemokines in vivo, which recites the importance of oatA in limiting innate immune responses, thereby promoting bacterial survival in the host.[8] This insertional inactivation of lmo0441 and lmo2229 (coding PBP3 and PBPA2, respectively) greatly reduces the intrinsic resistance of Lm to cephalosporins.[9] The patient B, who had a favorable outcome, was initiated on ampicillin with gentamicin following the culture reports, hence showed clinical recovery. The patient C was initiated on carbapenem, which did not modify the disease course and led to adverse outcomes. In this study, insertions and mutations reported in oatA and PBP3 gene were known to be the primary mechanism of resistance to higher generation cephalosporins. This study adds to the existing evidence on the resistance mechanisms of Lm and emphasises the importance of microbiological diagnosis, and also indicates the significance of considering the host predisposition before initiating empirical therapy with higher antibiotics such as cephalosporins or carbapenems.
Figure 1

Protein multialignment showing insertions and mutations in oatA gene

Protein multialignment showing insertions and mutations in oatA gene

Research quality and ethics statement

The authors followed applicable EQUATOR Network (https://www.equator-network.org/) guidelines, notably the CARE guideline, during the conduct of this report.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Epidemiology and risk management of listeriosis in India.

Authors:  S B Barbuddhe; S V S Malik; J Ashok Kumar; D R Kalorey; T Chakraborty
Journal:  Int J Food Microbiol       Date:  2011-09-08       Impact factor: 5.277

2.  Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe.

Authors:  Caitriona M Guinane; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  [Listeria monocytogenes disease].

Authors:  A Hernández-Milián; M García Gasalla; P Díaz Antolín; A Payeras Cifré
Journal:  Rev Clin Esp (Barc)       Date:  2014-02-05

4.  Epidemic listeriosis--evidence for transmission by food.

Authors:  W F Schlech; P M Lavigne; R A Bortolussi; A C Allen; E V Haldane; A J Wort; A W Hightower; S E Johnson; S H King; E S Nicholls; C V Broome
Journal:  N Engl J Med       Date:  1983-01-27       Impact factor: 91.245

5.  OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulence.

Authors:  Camille Aubry; Céline Goulard; Marie-Anne Nahori; Nadège Cayet; Jérémie Decalf; Martin Sachse; Ivo G Boneca; Pascale Cossart; Olivier Dussurget
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

6.  Detection of meningoencephalitis caused by Listeria monocytogenes with ischemic stroke-like onset using metagenomics next-generation sequencing: A case report.

Authors:  Xiaobo Zhang; Ruying Wang; Jie Luo; Danni Xia; Chaojun Zhou
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

Review 7.  Listeriosis: clinical presentation.

Authors:  Mehmet Doganay
Journal:  FEMS Immunol Med Microbiol       Date:  2003-04-01

Review 8.  Listeriosis: therapeutic options.

Authors:  Herbert Hof
Journal:  FEMS Immunol Med Microbiol       Date:  2003-04-01

9.  Clinical case report on treatment of Listeria monocytogenes meningoencephalitis: Intrathecal injection.

Authors:  Xu-Biao Pan; Zhi-Xin Wang; Ming-He Ma; Hong-Bin Wang; Gui-Fen Gan; Hai-Ning Fan
Journal:  Clin Case Rep       Date:  2018-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.